180 Life Sciences Corp. Quarterly Interest Expense in USD from Q2 2020 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
180 Life Sciences Corp. quarterly/annual Interest Expense history and growth rate from Q2 2020 to Q1 2024.
  • 180 Life Sciences Corp. Interest Expense for the quarter ending March 31, 2024 was $16.4K, a 42.3% increase year-over-year.
  • 180 Life Sciences Corp. Interest Expense for the twelve months ending March 31, 2024 was $49.7K, a 326% increase year-over-year.
  • 180 Life Sciences Corp. annual Interest Expense for 2023 was $44.8K, a 59.1% increase from 2022.
  • 180 Life Sciences Corp. annual Interest Expense for 2022 was $28.2K, a 10.8% increase from 2021.
  • 180 Life Sciences Corp. annual Interest Expense for 2021 was $25.4K, a 86.2% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $49.7K $16.4K +$4.89K +42.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $44.8K $10K +$24.6K Oct 1, 2023 Dec 31, 2023 10-K 2024-03-25
Q3 2023 $20.2K $11.6K +$4.29K +58.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $15.9K $11.6K +$4.25K +57.8% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-15
Q1 2023 $11.7K $11.6K -$16.5K -58.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $28.2K -$14.6K +$82.1K +84.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-25
Q3 2022 -$53.9K $7.35K +$1.89K +34.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$55.8K $7.36K -$4.89K -39.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-15
Q1 2022 -$50.9K $28.1K -$76.4K -73.1% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $25.4K -$96.7K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $5.46K -$77.5K -93.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $12.2K -$160K -92.9% Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $104K Jan 1, 2021 Mar 31, 2021 10-Q 2021-07-19
Q3 2020 $83K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $172K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.